Electrical Skin Conductance Monitoring as an Assessment of Post Operative Pain Scores
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Pain has been defined as a subjective experience. Various pain assessment tools, (such as NRS) have been developed and validated to objectively monitor and treat pain. There are certain patient populations, in whom, the current pain assessment tools cannot be used effectively due to communication problems such as cognitively impaired patients. In the US, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has made it mandatory to monitor and treat pain. In the absence of reliable pain assessment tools that would objectively measure pain, there is also risk of under treatment and overtreatment of pain that may lead to negative outcomes. Therefore, a monitor that is able to predict pain levels objectively, will help to achieve above goals. The investigators are using Skin Conductance Algesimeter (SCA) to measure pain by analyzing changes in skin conductance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 17, 2015
CompletedFirst Posted
Study publicly available on registry
April 3, 2015
CompletedResults Posted
Study results publicly available
December 18, 2017
CompletedAugust 28, 2019
August 1, 2019
8 months
February 17, 2015
March 27, 2017
August 13, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Numeric Pain Rating Scale
Numeric Pain Rating Scale, 0 (no pain) to 10 (worst pain)
Baseline, Postoperative day 1, Postoperative Day 2
Skin Conductance Response
A skin conductance response is defined as a minimum followed by a maximum in conductance values micro Siemens (mS).
Baseline, Postoperative day 1, Postoperative day 2
Secondary Outcomes (1)
Nausea
Baseline, Postoperative day 1, Postoperative day 2
Study Arms (1)
Total Hip Replacement (THR) and Total Knee Replacement (TKR)
25 patients receiving a THR and 25 patients receiving aTKR. The investigators are using Skin Conductance Algesimeter (SCA) to measure pain by analyzing changes in skin conductance.
Interventions
Total Hip Replacement is a surgical procedure where the cartilage and bone of the hip joint is replaced with artificial materials. Total Knee Replacement involves replacement of all three compartments of the knee the medial, the lateral and patellofemoral compartment.
Eligibility Criteria
Patients undergoing surgery for unilateral Total Hip Replacement and Total Knee Replacement.
You may qualify if:
- Patients undergoing unilateral THR and TKR who are between the ages of 18 and 85 regardless of the anesthesia and postoperative analgesia type.
- Patients participating in other studies may participate in this study as well
- Patients with Motor Activity Assessment Scale (MAAS) Score of 3 and 4
You may not qualify if:
- Age \<18, \>85
- History of chronic pain as defined by use of long acting opioid medication \> 6 months duration.
- MAAS Score of \<3 and \>4.
- Anticholinergic agent use
- Patients with the following conditions:
- Autonomic neuropathy
- Pacemaker/AICD
- Burn patients or patients with severe dermatologic conditions (as defined by skin conditions causing further pain to patients that actively has to be treated)
- Allergy to adhesive tape
- Communication barriers
- Bilateral Procedures
- Patient with diagnosis of
- Dysautonomia
- Sympathetic dysfunction such as: Raynaud disease, Buerger disease
- Disorders of sweating such as: Acquired idiopathic generalized anhidrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital for Special Surgery, New Yorklead
- Oslo University Hospitalcollaborator
- Weill Medical College of Cornell Universitycollaborator
Related Publications (3)
Devlin JW, Boleski G, Mlynarek M, Nerenz DR, Peterson E, Jankowski M, Horst HM, Zarowitz BJ. Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999 Jul;27(7):1271-5. doi: 10.1097/00003246-199907000-00008.
PMID: 10446819BACKGROUNDKunimoto M, Kirno K, Elam M, Wallin BG. Neuroeffector characteristics of sweat glands in the human hand activated by regular neural stimuli. J Physiol. 1991 Oct;442:391-411. doi: 10.1113/jphysiol.1991.sp018799.
PMID: 1798033BACKGROUNDStorm H, Shafiei M, Myre K, Raeder J. Palmar skin conductance compared to a developed stress score and to noxious and awakening stimuli on patients in anaesthesia. Acta Anaesthesiol Scand. 2005 Jul;49(6):798-803. doi: 10.1111/j.1399-6576.2005.00665.x.
PMID: 15954962BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Gungor
- Organization
- HSS
Study Officials
- PRINCIPAL INVESTIGATOR
Semih Gungor, MD
Hospital for Special Surgery, New York
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2015
First Posted
April 3, 2015
Study Start
November 1, 2010
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
August 28, 2019
Results First Posted
December 18, 2017
Record last verified: 2019-08